Amoxil

This page contains recent news articles, when available, and an overview of Amoxil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Amoxil (when available)

Pharmacology and use:
Zonisamide is used primarily as an anticonvulsant for the adjunctive treatment of epilepsy. The precise mechanism by which Zonisamide exerts its antiseizure effect is unknown, although it is believed that the drug blocks sodium channels which leads to the suppression of neuronal hypersynchronization (i.e. convulsions). Likewise Zonisamide has also been found not to potentiate syanptic activity by GABA (gamma amino butyric acid). Adjunctive treatment of partial seizures in adults with epilepsy.

Mechanism Of Action:
Zonisamide binds to sodium channels, voltage sensitive calcium channels and to a lesser extent carbonic anhydrase. This blocks or suppresses neuronal depolarization and hypersynchronization.

News Articles on Zonisamide

Frank Corbett, medical advertising great, dies - ‎Dec 11, 2009‎
The shop pioneered the use of feedback mechanisms in direct mail and new media in details (Super 8 film, in this case, for Beecham's Amoxil), and was ahead ... Medical Marketing and Media

Q&A: What are my rights? - ‎Nov 9, 2009‎
One of the drugs was amoxil but the pharmacist misread the written prescription and instead prescribed daonil, a medicine designed to lower blood sugar, ... Irish Independent

Brand Names/Synonyms:
Amoxil is also known by the following brand names and/or synonymsAD-810; Aleviatin; CHEMBANK2998; CI-912; Exceglan; Excegram; Excegran; Zonegran; Zonisamida [Spanish]; Zonisamide; Zonisamide [Usan:Ban:Inn:Jan]; Zonisamidum [Latin]

Drug Category:
Amoxil is categorized under the following by the FDA: Antioxidants; Anticonvulsants; ATC:N03AX15

Dosage Forms:
Capsules or tablets

Absorption:
Time to peak concentration is 2.8-3.9 hours

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
benzo[d]isoxazol-3-ylmethanesulfonamide

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.